Literature DB >> 15331193

Lymphangioleiomyomatosis.

Marilyn K Glassberg1.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare idiopathic disease predominately affecting women. The disease is characterized by peribronchial, perivascular, and perilymphatic proliferation of smooth muscle like cells resulting in vascular and airway obstruction and cyst formation. The natural history of pulmonary LAM is unknown, and it displays remarkable diversity in its clinical course. More than 400 citations are currently listed in the literature for LAM. This article reviews and updates the rapidly expanding knowledge about LAM.

Entities:  

Mesh:

Year:  2004        PMID: 15331193     DOI: 10.1016/j.ccm.2004.05.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  12 in total

1.  Mediastinal lymphangiomyoma in an adult: Report of a case.

Authors:  Hideki Ota; Yoshihiko Kimura; Hideki Kawai; Jun-ichi Ogawa
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.

Authors:  Alexandre Franco Amaral; Martina Rodrigues de Oliveira; Olívia Meira Dias; Fábio Eiji Arimura; Carolina Salim Gonçalves Freitas; Milena Marques Pagliarelli Acencio; Vanessa Adélia de Alvarenga; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho; Bruno Guedes Baldi
Journal:  Lung       Date:  2019-01-08       Impact factor: 2.584

3.  Air travel in women with lymphangioleiomyomatosis.

Authors:  Stacey Pollock-BarZiv; Marsha M Cohen; Gregory P Downey; Simon R Johnson; Eugene Sullivan; Francis X McCormack
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

4.  The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Authors:  Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo Taveira-Dasilva; Francis X McCormack; Nilo A Avila; Rosamma M Decastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

5.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

Review 6.  Rare lung diseases I--Lymphangioleiomyomatosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2006-10       Impact factor: 2.409

Review 7.  Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Authors:  Stephen C Juvet; Francis X McCormack; David J Kwiatkowski; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-10       Impact factor: 6.914

8.  Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.

Authors:  Rachel B Issaka; Saji Oommen; Shiv K Gupta; Gang Liu; Jeffrey L Myers; Jay H Ryu; Nicholas E Vlahakis
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

9.  Anesthesia for suboccipital craniotomy in a patient with lymphangioleiomyomatosis: a case report.

Authors:  Robert A Peterfreund; Emily Luman; Robert L Martuza
Journal:  Case Rep Pulmonol       Date:  2012-07-29

10.  Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis.

Authors:  Paola Contini; Mario Schiavina; Riccardo Schiavina; Francesco Tavalazzi; Andrea Fabiani; Valerio Di Scioscio; Paolo Spagnolo; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2011-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.